EKF Diagnostics Holdings plc announced the launch of its new Biosen C-Line (“Biosen”).
The new and updated analyzer has been designed to enhance usability with the latest color, touch screen and advanced connectivity, enabling the Biosen to seamlessly connect with hospital and laboratory IT systems, via EKF Link, to ensure patient results are quickly and securely available to clinicians.
The Biosen analyzer measures glucose and lactate levels in whole blood, plasma and serum, using enzymatic sensor technology to give results, less than 3% CV. It is used by clinical professionals in both primary and secondary care settings around the world to provide glucose analysis for the detection and management of diabetes.
The new Biosen is also compatible with EKF Link, a middleware solution for healthcare providers to manage their POC analyzers and the generated data on one centralized platform. This enables real-time remote management of data, including patient test results, quality control /calibration results, operator management and analyzer configuration. It is a fast and secure method for connecting POC devices to hospital and laboratory IT systems, enabling the safe and rapid transfer of data from the analyzer to the hospital or laboratory database for subsequent processing. Additionally all new Biosen devices have USB and encrypted ethernet interfaces.
